Marker Therapeutics (MRKR) vs Palatin Technologies (PTN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Palatin Technologies (PTN) has outperformed Marker Therapeutics (MRKR) over the past year, gaining 30.9% versus a loss of 1.9%. Over five years, MRKR leads with a -93.5% price change compared with -98.2% for PTN. Palatin Technologies is the larger company by market cap ($16.5 million vs $16.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MRKR | PTN |
|---|---|---|
| Share price | $0.9701 | $9.27 |
| Market cap | $16.17M | $16.51M |
| 1-day change | -6.72% | -2.60% |
| YTD return | -30.20% | -38.10% |
| 1-year return | -1.89% | +30.95% |
| 5-year return | -93.46% | -98.23% |
| EPS (TTM) | $-0.42 | $-2.96 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.46 | $31.00 |
| 52-week low | $0.84 | $5.61 |
| Distance from 52-week high | -60.57% | -70.09% |
| Average volume | 64.80K | 62.10K |
| Shares outstanding | 16.67M | 1.78M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PTN has outperformed MRKR by 32.8 percentage points over the past year.
MRKR vs PTN FAQ
Which is bigger, Marker Therapeutics or Palatin Technologies?
Palatin Technologies (PTN) is larger, with a market capitalization of $16.51M compared with $16.17M for Marker Therapeutics (MRKR).
Which stock has performed better over the past year, MRKR or PTN?
PTN returned +30.95% over the past 12 months, compared with -1.89% for MRKR (price return, excluding dividends). Past performance does not predict future results.
Are Marker Therapeutics and Palatin Technologies in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.